Analysis of cognitive status in patients with type 2 diabetes

Background: Cognitive impairment is a common complication of type 2 diabetes, greatly reduce the quality of life and daily functioning of patients, as well as have an impact on their compliance to therapy. Aim: Explore the nature and frequency of cognitive impairment in patients with type 2 diabete...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irina V. Gatckikh, Marina M. Petrova, Olga F. Veselova, Tatyana P. Shalda, Artem N. Narkevich, Irina N. Brickman
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/ea0a3f61fe7a4611a2fa47043c44de0f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea0a3f61fe7a4611a2fa47043c44de0f
record_format dspace
spelling oai:doaj.org-article:ea0a3f61fe7a4611a2fa47043c44de0f2021-11-14T09:00:21ZAnalysis of cognitive status in patients with type 2 diabetes2072-03512072-037810.14341/DM7926https://doaj.org/article/ea0a3f61fe7a4611a2fa47043c44de0f2017-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7926https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background: Cognitive impairment is a common complication of type 2 diabetes, greatly reduce the quality of life and daily functioning of patients, as well as have an impact on their compliance to therapy. Aim: Explore the nature and frequency of cognitive impairment in patients with type 2 diabetes, their relation to carbohydrate metabolism. Materials and methods: The study involved 113 patients with type 2 diabetes aged 40–70 years, with disease duration of more than 12 months; Control group consisted of 33 persons, stateless persons with type 2 diabetes, matched by age, sex, level of education, the presence of cardiovascular diseases such as hypertension and coronary heart disease. The complex included a survey of clinical and laboratory tests, instrumental, neuropsychological testing. To screen for cognitive impairment used by the Montreal Cognitive Assessment Scale (MоСа test), for the study of the frontal functions FAB (frontal dysfunction battery). Results: The study of cognitive impairment were diagnosed in 53,1 ± 9,2% of patients with type 2 diabetes, which is statistically significantly higher than in those in the control group 15,2 ± 12,2%. In patients with type 2 diabetes prevailed violations fronto-subcortical type with a reduction in short-term memory function, attention and constructive praxis. Cognitive impairment correlated with indices of carbohydrate metabolism (HbA1c, fasting glucose), disease duration 7 [5, 12] years and the patient's. Conclusions: These data confirm the impact of hyperglycemia as a major pathogenic factor and duration of the disease on the formation and progression of cognitive impairment in patients with type 2 diabetes.Irina V. GatckikhMarina M. PetrovaOlga F. VeselovaTatyana P. ShaldaArtem N. NarkevichIrina N. BrickmanEndocrinology Research Centrearticletype 2 diabetescognitive impairmentneuropsychological testingmoса-testNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 6, Pp 434-440 (2017)
institution DOAJ
collection DOAJ
language EN
RU
topic type 2 diabetes
cognitive impairment
neuropsychological testing
moса-test
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle type 2 diabetes
cognitive impairment
neuropsychological testing
moса-test
Nutritional diseases. Deficiency diseases
RC620-627
Irina V. Gatckikh
Marina M. Petrova
Olga F. Veselova
Tatyana P. Shalda
Artem N. Narkevich
Irina N. Brickman
Analysis of cognitive status in patients with type 2 diabetes
description Background: Cognitive impairment is a common complication of type 2 diabetes, greatly reduce the quality of life and daily functioning of patients, as well as have an impact on their compliance to therapy. Aim: Explore the nature and frequency of cognitive impairment in patients with type 2 diabetes, their relation to carbohydrate metabolism. Materials and methods: The study involved 113 patients with type 2 diabetes aged 40–70 years, with disease duration of more than 12 months; Control group consisted of 33 persons, stateless persons with type 2 diabetes, matched by age, sex, level of education, the presence of cardiovascular diseases such as hypertension and coronary heart disease. The complex included a survey of clinical and laboratory tests, instrumental, neuropsychological testing. To screen for cognitive impairment used by the Montreal Cognitive Assessment Scale (MоСа test), for the study of the frontal functions FAB (frontal dysfunction battery). Results: The study of cognitive impairment were diagnosed in 53,1 ± 9,2% of patients with type 2 diabetes, which is statistically significantly higher than in those in the control group 15,2 ± 12,2%. In patients with type 2 diabetes prevailed violations fronto-subcortical type with a reduction in short-term memory function, attention and constructive praxis. Cognitive impairment correlated with indices of carbohydrate metabolism (HbA1c, fasting glucose), disease duration 7 [5, 12] years and the patient's. Conclusions: These data confirm the impact of hyperglycemia as a major pathogenic factor and duration of the disease on the formation and progression of cognitive impairment in patients with type 2 diabetes.
format article
author Irina V. Gatckikh
Marina M. Petrova
Olga F. Veselova
Tatyana P. Shalda
Artem N. Narkevich
Irina N. Brickman
author_facet Irina V. Gatckikh
Marina M. Petrova
Olga F. Veselova
Tatyana P. Shalda
Artem N. Narkevich
Irina N. Brickman
author_sort Irina V. Gatckikh
title Analysis of cognitive status in patients with type 2 diabetes
title_short Analysis of cognitive status in patients with type 2 diabetes
title_full Analysis of cognitive status in patients with type 2 diabetes
title_fullStr Analysis of cognitive status in patients with type 2 diabetes
title_full_unstemmed Analysis of cognitive status in patients with type 2 diabetes
title_sort analysis of cognitive status in patients with type 2 diabetes
publisher Endocrinology Research Centre
publishDate 2017
url https://doaj.org/article/ea0a3f61fe7a4611a2fa47043c44de0f
work_keys_str_mv AT irinavgatckikh analysisofcognitivestatusinpatientswithtype2diabetes
AT marinampetrova analysisofcognitivestatusinpatientswithtype2diabetes
AT olgafveselova analysisofcognitivestatusinpatientswithtype2diabetes
AT tatyanapshalda analysisofcognitivestatusinpatientswithtype2diabetes
AT artemnnarkevich analysisofcognitivestatusinpatientswithtype2diabetes
AT irinanbrickman analysisofcognitivestatusinpatientswithtype2diabetes
_version_ 1718429562676707328